Diagnosis and Management of IBS-C for the Primary Care Provider
1.00 AMA PRA Category 1 Credits
Click here to download the IBS Patient Waiting Room Tool
Upon completion of this activity, participants should be able to:
- Differentiate IBS-C from other common gastrointestinal motility disorders
- Apply symptom-based criteria to the diagnosis of patients with suspected IBS-C
- Design effective treatment strategies for patients with IBS-C
- Educate patients regarding reasonable expectations for various IBS-C therapies
- Summarize current data on therapies in development for the treatment of IBS-C
Continuing Education in the Penn State College of Medicine works to extend the academic expertise of the campus’s clinical and basic sciences. The department aims to develop and implement an integrated program of continuing professional education for health professionals on campus, in the community, throughout the Commonwealth, and at times across the nation and the world. Educational activities also provide the latest information on selected health topics to lay professionals and the general public.
||AMA PRA Category 1 Credits
||Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity is co-sponsored by Curatio CME Institute, an ACCME-accredited provider. If you have any questions relating to the accreditation or your certificate for this activity, please contact Penn State at ContinuingEd@hmc.psu.edu or (717) 531-6483. Reference course #G5170-13-T
||Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Editorial Board
Lin Chang, MD, Professor of Medicine, Department of Medicine, Division of Digestive Diseases, Co-Director, Center for Neurobiology of Stress, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California
William D. Chey, MD, AGAF, FACG, FACP, Professor of Medicine, Director, GI Physiology Laboratory, Co-Director, Michigan Bowel Control Program, H. Marvin Pollard Institute Scholar, Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan
Thomas Finnegan, PhD, Associate Medical Director, Curatio CME Institute
Jonathan S. Simmons, ELS, Senior Managing Editor, Curatio CME Institute
Financial Disclosure Statement(s)
Thomas Finnegan, PhD has nothing to disclose.
Jonathan S. Simmons, ELS has nothing to disclose.
Penn State faculty and staff have nothing to disclose.
Lin Chang, MD, has disclosed the following relevant financial relationships: Consultant (investigator-initiated study): Ironwood; Consultant: Forest; Consultant/Scientific Advisory Board: Lexicon, Marathon, Prometheus, Salix, Takeda; Investigator-initiated study: Shire
William D. Chey, MD, AGAF, FACG, FACP, has disclosed the following relevant financial relationships: Consultant: Astra Zeneca, Albireo, Asubio Pharmaceuticals, Forest, Ironwood, Perrigo, Prometheus, Salix, Smartpill, Takeda; Research Project: Ironwood
Estimated Time to Complete Activity: 1 hour
Co-sponsored by Curatio CME Institute and Penn State College of Medicine
Support for this activity has been provided through an educational grant from Forest Research Institute, a subsidiary of Forest Laboratories, Inc.
Instructions for Obtaining Credit:
Complete this online activity. Answer the questions in the attached post-activity assessment and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.
Computer System Requirements:
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, or DBC Pri-Med, LLC.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the Penn State College of Medicine, Curatio CME Institute, or Forest Research Institute, a subsidiary of Forest Laboratories, Inc.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.